Screening for lung cancer.

By R. Manser, A. Lethaby, L. Irving, C. Stone, G. Byrnes, M. Abramson, D. Campbell. Cochrane Database of Systematic Reviews, 2004

697 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/43a4daa74c349982974f23e9761ec35ffaef3bca

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Jemal
2. R. Siegel
3. Elizabeth E. Ward
4. Brenda K. Edwards
5. H. Welch
6. H. Macmahon
7. L. Clegg
8. P. Bach

Citations in the corpus

• Current and Future Development in Lung Cancer Diagnosis (2021, result): “However, results showed that these two screening methods failed in clinical trials and could not demonstrate their efficacy as mass screening tools [9].”
• Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival (2004, background): “However, the introduction of or improvements in early detection or diagnostic tests may increase observed survival rates spuriously by advancing the time of diagnosis of disease without prolonging life (lead-time bias), by the preferential detection of slower growing tumors (length-time bias), or by”
• Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. (2005, background): “As summarized above, data from ongoing CT screening programs with multidetector CT with 5-mm collimation indicate that approximately half of all smokers over 50 years of age have at least one lung nodule on the initial scan (36).”
• Overdiagnosis in cancer. (2010, background): “The Mayo trial of chest x-ray and sputum cytology screening (16) provided strong evidence for lung cancer overdiagnosis.”
• Variations in lung cancer risk among smokers. (2003, background): “Conceivably, risk prediction could even be used to help determine whether highly sensitive screening technologies such as computed tomography (CT) lead to overdiagnosis of lung cancer by comparing the rates of predicted and detected incident disease within a screened population (3, 4 ).”
• American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. (2004, unknown): “College of Radiology Imaging Network [257,263].”